Skip to main content

Advertisement

Log in

Susceptibility ofCampylobacter species to niridazole

  • Notes
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Karmali, M. A., de Grandis, S., Fleming, P. C.: Antimicrobial susceptibility ofCampylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrobial Agents and Chemotherapy 1981, 19: 593–597.

    PubMed  Google Scholar 

  2. Hof, H., Sticht-Groh, V., Muller, K.-M.: Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria. Antimicrobial Agents and Chemotherapy 1982, 22: 332–333.

    PubMed  Google Scholar 

  3. Hof, H., Sticht-Groh, V.: Antibacterial effects of niridazole: its effect on microaerophilic campylobacter. Infection 1984, 12: 36–39.

    Article  PubMed  Google Scholar 

  4. Hof, H., Reiffert, M., Sticht-Groh, V., Zak, O., Schweizer, E. H.: Antibacterial activites of nitrothiazole againstCampylobacter jejuni andCampylobacter coli. Antimicrobial Agents and Chemotherapy 1984, 26: 498–500.

    PubMed  Google Scholar 

  5. Freydiere, A. M., Gille, Y., Tigaud, S., Vincent, P.: In vitro susceptibilities of 40Campylobacter fetus subsp.jejuni strains to niridazole and metronidazole. Antimicrobial Agents and Chemotherapy 1984: 145–146.

  6. Reed, L. J., Muench, H.: A simple method for estimating fifty per cent end points. American Journal of Hygiene 1938, 27: 493–497.

    Google Scholar 

  7. Valencia, C. I., Catt, B. A., Fairchild, E. H., Wilson, S. B., Maramba, N. C., Webster, L. T.: Concentration-time course of niridazole and six metabolites in the serum of four Filipinos withSchistosoma japonicum infection. Journal of Pharmacology and Experimental Therapeutics 1984, 230: 133–140.

    PubMed  Google Scholar 

  8. Bokkenheuser, V.: Vibrio fetus infections in man: ten new cases and some epidemiologic observations. American Journal of Epidemiology 1970, 91: 400–409.

    PubMed  Google Scholar 

  9. Tauxe, R. V., Patton, C. M., Edmonds, P., Barrett, T. J., Brenner, D. J., Blake, P. A.: Illness associated withCampylobacter laridis, a newly recognized Campylobacter species. Journal of Clinical Microbiology 1985, 22: 222–225.

    Google Scholar 

  10. Nachamkin, I., Stowell, C., Skalina, D. J., Jones, A. M., Hoop, R. M., Smibert, R. M.:Campylobacter laridis causing bacteremia in an immunocompromised host. Annals of Internal Medicine 1984, 101: 55–57.

    PubMed  Google Scholar 

  11. Goodwin, C. S., Armstrong, J. A., Marshall, B. J.:Campylobacter pyloridis, gastritis, and peptic ulceration. Journal of Clinical Pathology 1986, 39: 353–365.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bannatyne, R.M., Karmali, M.A., Jackowski, J. et al. Susceptibility ofCampylobacter species to niridazole. Eur. J, Clin. Microbiol. 5, 664–665 (1986). https://doi.org/10.1007/BF02013295

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013295

Keywords

Navigation